Document is current
Any future updates will be listed below
-
Authors
Austin, Andrea M. https://orcid.org/0000-0002-4404-6065
Henderson, Scott C.
Trujillo, Natasha C.
Low, Robert
Eliot, Melissa
Main, Sandra I.
Litman, Heather J.
Nabavian, Omeed
-
Funding
Funding for this research was provided by:
Thermo Fisher Scientific
UCB US
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 22 December 2025
First Online: 19 January 2026
Declarations
:
: Andrea M. Austin and Heather J. Litman are employees and shareholders of Thermo Fisher Scientific. Scott C. Henderson and Melissa Eliot are employees of Thermo Fisher Scientific. Natasha C. Trujillo, Robert Low and Omeed Nabavian are employees and shareholders of UCB. At the time of the study, Sandra I. Main was an employee of Thermo Fisher Scientific.
: The study was performed in accordance with the Declaration of Helsinki and the Guidelines for Good Pharmacoepidemiology Practice (GPP). All participating investigators were required to obtain full board approval for conducting non-interventional research involving human subjects with a limited dataset. Sponsor approval and continuing review was obtained through a central institutional review board (IRB, Advarra, Protocol Number Pro00051221). For academic investigative sites that did not receive a waiver to use the central IRB, full board approval was obtained from the respective governing IRBs and documentation of approval was submitted to Thermo Fisher Scientific prior to the initiation of any study procedures. All patients in the registry were required to provide written informed consent and authorization prior to participating.
